Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2
Figure 2
(A) Immunohistochemistry results in sham-operated, model, fosinopril sodium, and QSYQ groups (400x magnifications). (a) Cardiac Ang II expression in sham-operated group. (b) Upregulated cardiac Ang II expression in model group. (c) Fosinopril sodium reduced the level of Ang II. (d) Cardiac Ang II expression decreased in QSYQ group. (B) The OD ratio of cardiac Ang II expression. All values are means SD (). compared with model group.
